CLEVELAND CLINIC • 2026 EDITION
Cleveland Clinic Nephrology Update 2026
Cleveland Clinic Nephrology Update 2026 delivers a comprehensive review of current scientific evidence and its practical implications for the diagnosis and management of kidney disease.
Course Details
Cleveland Clinic Nephrology Update 2026
Original Dates: April 29 – May 1, 2026 • Cleveland, Ohio
Format: Videos + VTT subtitle files + PDFs • Total size: — GB
About Cleveland Clinic Nephrology Update 2026
Cleveland Clinic Nephrology Update 2026 is designed to provide a comprehensive review of the most up-to-date scientific data and analyze its implications for clinical practice. The program focuses on recent and emerging topics that directly affect day-to-day patient care.
Led by expert faculty, the course addresses current diagnostic and management strategies for patients with a wide range of kidney diseases. Major areas include hypertension, cardiovascular-kidney-metabolic syndrome, cystic kidney diseases, glomerular diseases, vasculitis, acute kidney injury, cardiorenal and hepatorenal syndromes, and kidney complications related to cancer treatment.
The program combines evidence-based updates, practical case discussions, journal clubs, clinicopathologic reviews, and palliative medicine workshops to help clinicians translate new knowledge into better patient care.
Why Choose This Course
âś“ Expert Cleveland Clinic faculty presenting current clinical evidence
âś“ Comprehensive coverage of chronic kidney disease, glomerular disease, hypertension, and AKI
âś“ Practical case discussions and clinicopathologic review sessions
âś“ Updates on emerging therapies and evolving treatment strategies
âś“ Dedicated sessions on kidney disease in oncology and critical care
âś“ Palliative medicine workshops for complex kidney disease management
Learning Objectives
Upon Completion, Participants Will Be Able To
âś“ Describe advances in the management of ADPKD and other cystic kidney diseases and review their impact on clinical practice.
âś“ Review the pathogenesis and treatment of IgA nephropathy, anti-GBM disease, ANCA-associated glomerulonephritis, lupus nephritis, thrombotic microangiopathy, and APOL1 nephropathy.
âś“ Summarize the safety and efficacy of newer therapies for hypertension, including renal denervation, aldosterone synthase inhibitors, endothelin receptor therapies, and hepatic angiotensinogen-silencing RNA.
âś“ Describe the practical use of emerging therapies for patients with resistant hypertension.
âś“ Evaluate the latest evidence-based treatment strategies for hepatorenal and cardiorenal syndromes.
âś“ Apply updated approaches to kidney-related complications in patients with cancer, including nephrotoxicity from immune checkpoint inhibitors and targeted cancer therapies.
Key Clinical Areas
Chronic Kidney Disease: Mineral Bone Disease • Metabolic Acidosis • Hyperkalemia • Cardiovascular Risk Reduction
Glomerular Disease: IgA Nephropathy • Anti-GBM Disease • ANCA Vasculitis • Lupus Nephritis • APOL1 Nephropathy • TMA
Hypertension: Resistant Hypertension • Hyperaldosteronism • Renal Denervation • Emerging Medical Therapies
Cystic Kidney Disease: ADPKD • Non-ADPKD Disorders • Case-Based Management
Special Populations: Cancer • Intensive Care • Cardiorenal Syndrome • Hepatorenal Syndrome • Palliative Care
Complete Topics and Sessions
Cleveland Clinic Nephrology Update 2026 Curriculum
01. Mineral Bone Disease in CKD
02. Metabolic Acidosis in CKD
03. Saving Kidneys, Hearts, and Lives: Understanding Cardiovascular-Kidney-Metabolic Syndrome
04. Hyperkalemia and RAAS Inhibitors: Saving Kidneys, Hearts, and Lives
05. GLP-1 RA and the Kidneys: A Nephrologist Perspective
06. Cardiovascular Risk Reduction and Hyperlipidemia Management in CKD
07. ADPKD Update
08. Non-ADPKD Cystic Kidney Disease Cases
09. Case Discussions in ADPKD
10. Journal Club 1
11. Journal Club 2
12. APOL1 Nephropathy
13. Precision Medicine in Glomerular Diseases: NEPTUNE Match
14. Update on ANCA Disease: Reducing the Steroid Burden
15. IgA Nephropathy: Update on Pathogenesis and Treatment
16. Complement Across Glomerular Diseases
17. Clinicopathologic Case Discussions
18. Introduction: Kasperzak Talk
19. Kasperzak Talk — Anti-GBM Disease: A State-of-the-Art Update
20. Future Directions in Lupus Nephritis Management
21. Select Cases from the Cleveland Clinic GN Clinic
22. Thrombotic Microangiopathy: aHUS and Beyond
23. Clinicopathologic Case Discussions
24. Hypertension Guidelines Update
25. Update on Hyperaldosteronism
26. Practical Approach to Resistant Hypertension
27. Medical Therapy in Hypertension: An Evolving Landscape
28. Update on Renal Denervation
29. Innovations in Blood Pressure Measurement
30. Updates in Hepatorenal Syndrome
31. Cardiorenal Syndrome
32. Acute Kidney Injury in Cancer
33. Acute Kidney Injury in the ICU
34. Palliative Medicine Workshop 1
35. Palliative Medicine Workshop 2
36. Session I: Cardiovascular-Kidney-Metabolic Syndrome, Part I
37. Session II: Cardiovascular-Kidney-Metabolic Syndrome, Part II
38. Session III: Cystic Kidney Diseases
39. Session IV: Journal Club
40. Session V: Glomerular Disease Update, Part I
41. Session VI: Glomerular Disease Update, Part II
42. Session VII: Glomerular Disease Update, Part III
43. Session VIII: Glomerular Disease Update, Part IV
44. Session IX: Hypertension Updates, Part I
45. Session X: Hypertension Updates, Part II
46. Session XI: AKI in Special Populations, Part I
47. Session XII: AKI in Special Populations, Part II
Target Audience
This activity is designed for healthcare professionals seeking an update on recent advances in chronic kidney disease management and treatment strategies.
âś“ Nephrologists
âś“ Cardiologists
âś“ Critical Care Physicians and Intensive Care Specialists
âś“ Oncologists
âś“ Palliative Medicine Specialists
âś“ Internists
âś“ Nurses and Nurse Practitioners
âś“ Physician Assistants
âś“ Other clinicians involved in kidney disease management
Delivery and Access
Videos + VTT + PDFs
The package includes video lectures, matching VTT subtitle files, and PDF educational resources.
Total Size: — GB
The final file count and total package size can be added once confirmed.
Lifetime Access
One-time purchase with permanent access to the supplied digital course files.
Multiple Devices
Compatible with desktop, laptop, tablet, and mobile devices supporting video, VTT, and PDF formats.
Educational Use Notice: This digital course package is provided for educational purposes only. No certificate, CME credit, MOC credit, or contact hours are included with the digital files.
Reviews
There are no reviews yet.